| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 09/06/2006 | CN1827601A Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/06/2006 | CN1827600A Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 09/06/2006 | CN1827599A Crystalline form beta-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it |
| 09/05/2006 | US7101870 2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; treating Alzheimer's disease and Down's Syndrome by inhibiting production of A beta -peptide |
| 08/31/2006 | WO2006091301A2 Passcodes |
| 08/31/2006 | WO2006090044A1 Lactam production method |
| 08/31/2006 | WO2006056696A3 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/31/2006 | WO2006023187A3 Cycloalkylamine derivatives as nk-1 /ssri antagonists |
| 08/31/2006 | US20060194967 Process for the preparation of Fenoldopam Mesylate |
| 08/31/2006 | US20060194964 Gamma d-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 08/31/2006 | US20060194963 Procoralan; brandycardial agent: angina pectoris, myocardial infarct, heart failure, myocardial ischaemia, supraventricular rhythm disturbances; stability and processability |
| 08/31/2006 | US20060194962 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 08/31/2006 | US20060194790 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194786 Process and intermediates for preparing benzazepines |
| 08/30/2006 | EP1695965A1 Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 08/30/2006 | EP1694334A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 08/29/2006 | US7098203 and selective serotonin reuptake inhibitors; 4-benzyloxymethyl-4-phenylazepanes; antidepressants; anxiety |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006075925A3 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 08/23/2006 | EP1692129A1 Keto lactam compounds and use thereof |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | CN1823059A Selective D1/dD receptor antagonists for the treatment of obesity and CNS disorders |
| 08/23/2006 | CN1823047A Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
| 08/23/2006 | CN1271167C Organic electroluminescent element |
| 08/23/2006 | CN1271057C Method for preparing 1-methyl-3-ethyl-3-(3-hydroxy phenyl)-hexa hydrogen-1 H azepin hydrochloride |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
| 08/17/2006 | US20060183896 Optically active quaternary ammonium salt, process for producing the same, and process for producing optically active alpha-amino acid derivative with the same |
| 08/17/2006 | US20060183732 Novel lactams and uses thereof |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820000A A method for the preparation of enantiomerically pure mirtazapine |
| 08/16/2006 | CN1817865A Preparation of sinomontanine and its hydrobromide |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269803C Process for preparing epsilon-caprolactam |
| 08/15/2006 | US7091339 Reacting the dibenz(b,f)azepaine with Group 1a, Group 2a cyanide |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688393A1 High silica cds-1 zeolite |
| 08/09/2006 | EP1687279A1 7- [4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinium maleate or tosylate as antipsychotics |
| 08/09/2006 | EP1687005A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | CN1268627C Process for preparing 1.8-diazadicyclo [5,4,0] -7 undecene |
| 08/08/2006 | US7087596 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 08/02/2006 | EP1685103A1 3-aminopyrrolidone derivatives |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | CN1810786A Synthesis of caprolactam and its oligomer |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/01/2006 | US7084154 Reducing pain |
| 07/27/2006 | WO2006078753A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | US20060166968 Crystalline form of oxcarbazepine |
| 07/27/2006 | US20060166966 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |
| 07/27/2006 | US20060165648 Compounds, compositions, and methods for controlling biofilms |
| 07/27/2006 | CA2595173A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | CA2593667A1 Process for the preparation of fenoldopam mesylate |
| 07/26/2006 | CN1809532A Method for making caprolactam |
| 07/26/2006 | CN1807429A Use of fern in extracting harringtonine or homoharringtonine |
| 07/26/2006 | CN1266136C Kinetic resolution of intermediate for preparing benazepril and its analogues |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/20/2006 | WO2006075925A2 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/20/2006 | US20060160894 Benzamides as ppar modulators |
| 07/20/2006 | CA2594869A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/19/2006 | EP1681291A1 Process for the preparation of norgalanthamine, its isomers, salts and hydrates |
| 07/19/2006 | EP1680406A1 N-substituted benzene sulfonamides |
| 07/19/2006 | EP1680405A1 Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 07/19/2006 | EP1680400A2 Derivatives of n-[ phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[ (azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/19/2006 | EP1680127A1 Benzazepine derivatives as mao-b inhibitors |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1325054B1 Twisted polymers, uses thereof and processes for the preparation of statistical copolymers |
| 07/19/2006 | CN1805939A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 07/19/2006 | CN1805938A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 07/19/2006 | CN1803760A N-arylation process with hydrazone as ligand in aqueous phase system |
| 07/19/2006 | CN1264808C Production of alkyl 6-aminocaproate |
| 07/18/2006 | US7078424 Central nervous system disorders; alopecia |
| 07/13/2006 | WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/12/2006 | EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative |
| 07/12/2006 | EP1679069A1 Novel piperidine derivative |
| 07/12/2006 | EP1678140A2 Novel process for preparation of 10-oxo-10, 11-dihydro-5h-dibenz [b,f]azepine-5-carboxamide (oxcarbazepine) via intermediate, 10-methoxy-5h-dibenz [b,f] azepine-5-carbonylchloride |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | CN1802356A Alkylated iminodibenzyls as antioxidants |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/11/2006 | US7074920 Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/06/2006 | WO2006046039A3 Tetracyclic indole derivatives as antiviral agents |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/04/2006 | US7071211 Vision disorders; adjustment activation of gelatinase |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | US20060142566 Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and new crystal forms thereof |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | CA2589988A1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1673347A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |